Home / Ropivacaine / United States
US ATC N01BB09 · updated 2 Nov 2026
Ropivacaine shortage in United States
Is there a Ropivacaine shortage in United States?
Yes. As of 2 Nov 2026, 49 Ropivacaine products are reported short in United States, the first since 23 Mar 2018. No return date has been given. Main reason: not stated.
Also short in Germany, Italy, Spain, Austria, Belgium, Czechia, Sweden, New Zealand. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Increased demand Demand increase for the drug |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Increased demand Demand increase for the drug |
| US | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Eugia US LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Eugia US LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Eugia US LLC | 23 Mar 2018 | not given | Increased demand Demand increase for the drug |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Eugia US LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Eugia US LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Eugia US LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Somerset Therapeutics, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Eugia US LLC | 23 Mar 2018 | not given | Increased demand Demand increase for the drug |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | InfoRLife SA | 27 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | InfoRLife SA | 27 Mar 2018 | not given | Other |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | InfoRLife SA | 27 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | InfoRLife SA | 27 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | InfoRLife SA | 27 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | InfoRLife SA | 27 Mar 2018 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Caplin Steriles, Ltd. | 22 Dec 2020 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) limited | Caplin Steriles, Ltd. | 22 Dec 2020 | not given | Other |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Caplin Steriles, Ltd. | 22 Dec 2020 | not given | Not stated |
| US | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) limited | Caplin Steriles, Ltd. | 22 Dec 2020 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).